Drug
Rotigotine 1 Milligram 24 Hours
Rotigotine 1 Milligram 24 Hours: highest development phase Phase 3, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rotigotine 1 milligram/24 hours NCT03728933 | Phase 3 | Restless Legs Syndrome |
Latest
No recent events.
Follow Rotigotine 1 Milligram 24 Hours on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.